Retrospective analysis finds gene fusions as potential prognostic biomarkers in advanced melanoma, suggesting new therapeutic targets for treatment.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nibeyro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: